In silico , in vitro and ex vivo characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants localized in the fourth intracellular loop and their rescue by modulators
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.70176 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Emanuela Pesce und 25 weiteren Autor:innen. Beteiligte Einrichtung: UOC Genetica Medica, IRCCS Istituto Giannina Gaslini, Genoa, Italy. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Aminophenols, Quinolones, Cystic Fibrosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Fondazione per la Ricerca sulla Fibrosi Cistica, Cystic Fibrosis Foundation.
Abstract (Originalsprache)
Background and Purpose Cystic fibrosis (CF) is due to loss‐of‐function variants of the CF transmembrane conductance regulator (CFTR) channel. The most effective treatment for people with CF carrying the F508del mutation is the triple combination of elexacaftor–tezacaftor–ivacaftor (ETI). ETI can correct the underlying defect(s) in other CFTR mutants. The use of disease‐relevant predictive models such as patient‐derived human nasal epithelial cells allow to investigate the response to CFTR modulators of specific genotypes, possibly supporting patients' access to treatment. Experimental Approach Using computational, biochemical and functional methodologies, a detailed analysis of selected variants in the intracellular loop 4 (ICL4) to understand their impact on CFTR structure and function. Key Results Mutations affecting L1065, R1066 and L1077 compromise structural stability of CFTR. Analyses of single variants expressed heterologously in immortalized bronchial cells showed that, upon ETI, rescued activity for both L1065P and R1066C was close to 50% of the wild‐type CFTR activity. Biochemical studies of ICL4 variants expression pattern in CFBE41o‐cells, following treatment for 24 h, demonstrate the appearance of the mature, fully glycosylated band, with no changes in the immature band. Finally, our study provides evidence in primary nasal cells from a cohort of people with CF that L1065P and R1066C can be effectively rescued by ETI up to 25%–45% of the activity measured in non‐CF epithelia. Conclusion and Implications Although the observed rescue for L1065P and R1066C was smaller than that of the F508del, it should fall in a range predicted, by various studies, to provide a clinical benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UOC Genetica Medica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
- School of Physics, The University of Sydney, Sydney, New South Wales, Australia.
- INSERM, CNRS, Institut Necker Enfants Malades, Paris, France.
- Université Paris-Cité, Paris, France.
- UOSD Centro Fibrosi Cistica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
ORCID-Profile: Luis J V Galietta, Nicoletta Pedemonte
Förderung
- Ministero della Salute
- Fondazione per la Ricerca sulla Fibrosi Cistica
- Cystic Fibrosis Foundation
- Simons Foundation
Zitieren
APA
Pesce, E., Tomati, V., Capurro, V., Lena, M., Pastorino, C., Astore, M., Kuyucak, S., Chevalier, B., Sondo, E., Cresta, F., Dighero, A., Terlizzi, V., Fevola, C., Costa, S., Lucanto, M. C., Daccò, V., Claut, L., Ficili, F., Fabrizzi, B., …, & Pedemonte, N. (2025). In silico , in vitro and ex vivo characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants localized in the fourth intracellular loop and their rescue by modulators. British Journal of Pharmacology. https://doi.org/10.1111/bph.70176
Vancouver
Pesce E, Tomati V, Capurro V, Lena M, Pastorino C, Astore M, et al. In silico , in vitro and ex vivo characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants localized in the fourth intracellular loop and their rescue by modulators. British Journal of Pharmacology. 2025. doi:10.1111/bph.70176
BibTeX
@article{Pesce2025,
author = {Pesce, Emanuela and Tomati, Valeria and Capurro, Valeria and Lena, Mariateresa and Pastorino, Cristina and Astore, Miro and Kuyucak, Serdar and Chevalier, Benoit and Sondo, Elvira and Cresta, Federico and Dighero, Alice and Terlizzi, Vito and Fevola, Cristina and Costa, Stefano and Lucanto, Maria Cristina and Daccò, Valeria and Claut, Laura and Ficili, Francesca and Fabrizzi, Benedetta and Bocciardi, Renata and Zara, Federico and Castellani, Carlo and Galietta, Luis J V and Waters, Shafagh A and Hinzpeter, Alexandre and Pedemonte, Nicoletta},
title = {In silico , in vitro and ex vivo characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants localized in the fourth intracellular loop and their rescue by modulators},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.70176}
}
EUVIMED